维普期刊资源整合服务平台（V6.5）

203篇 您的检索式：作者名="Body JJ"

选中清除导出查看参考文献查看引证文献引用追踪共11页首页上一页第1页下一页末页 /11 跳转

	题名	作者	年代	出处	被引量
1	Dosing regimens and main adverse events of bisphosphonates显示文摘		2001	Semin Oncol2001，28，411：	1
2	Guidance on the use of bisphosphonates in solid tumours: re- commendations of an international expert panel显示文摘	Aapro M Abrahamsson PA Body JJ	2008	Ann Oncol2008，19，3：	1
3	Raloxifene显示文摘	Body JJ Sternon J	2000	Rev Med Brux2000，21，1：	1
4	Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study 显示文摘	Stopeck AT Lipton A Body JJ	2010	J Clin Oncol2010，28，35：	1
5	A prospective study on hyponatraemia in medical cancer patients:epidemiology, aetiology and differential dignosis显示文摘	Berghmans T Paesmans M Body JJ	2000	Support Care Cancer2000，8，3：	1
6	A prospective study on hyponatraemia in medical cancer patients : epidemiology, aetiology and differential diagnosis 显示文摘	Berghmans T Paesmans T Body JJ	2000	Support Care Cancer2000，8，3：	1
7	Clinical research update::Zoledronic显示文摘	Body JJ	1997	Cancer1997，15，8：	1
8	Pain outcomes in patients with advanced breast cancer and bone metastases:results from a randomized,double-blind study of denosumab and zoledronic acid显示文摘	Cleeland CS Body JJ Stopeck A		0，，04：	1
9	Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial 显示文摘	Pecherstorfer M Rivkin S Body JJ	2006	Clin Drug Investig2006，26，6：	1
10	Assessment of dyspnea in advanced cancer patients显示文摘	Mancini I Body JJ	1999	Support Care Cancer1999，7，4：	1
11	Breast cancer:bisphosphonate therapy for metastatic bone disease显示文摘	Body JJ	2006	Clin Cancer Res2006，12，202：	1
12	Intravenous ibandronate reduces the incidence of skeletal complication in patients with breast cancer and bone metastases 显示文摘	Body JJ Diel IJ Lichinitser MR	2003	Ann Oncol2003，14，9：	1
13	Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies显示文摘	Coleman RE Body JJ Gralow JR	2008	Cancer Treat Rev2008，34，1：	1
14	A dose-finding study of zoledronate in hypercalcemic cancer patients显示文摘	Body JJ Lortholary A Romieu G	1999	J Bone Miner Res1999，14，9：	1
15	A prospective study on hy-ponatraemia in medical cancer patients : epidemiology, etiology and dif-ferential dignosis显示文摘	Berghmans T Paesmans M Body JJ	2000	Support Care Cancer2000，8，：	1
16	Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer:a randomized,doubleblind study显示文摘	STOPECK AT LIPTON A BODY JJ	2010	J Clin Oncol2010，28，35：	1
17	Practical guidance for the management of aromatase inhibitor-associated bone loss显示文摘	Hadji P Body JJ Aapro MS	2008	Ann Oncol2008，19，8：	1
18	A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases显示文摘	Body JJ Greipp P Coleman RE	2003	Cancer2003，97，3：	1
19	Treatment of tumor-induced hypercalcemia: a solved problem?显示文摘	Body JJ Mancini I	2003	Expert Rev Anticancer Ther2003，3，2：	1
20	A dose-finding study of zoledronate in hypercalcemic cancer patients显示文摘	Body JJ Lortholary A Romieu G	1999	J Bone Miner Res1999，14，9：	1

返回顶部每页显示：

共11页首页上一页第1页下一页末页 /11 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示